Association of Serum Cholesterol Efflux Capacity With Mortality in Patients With ST-Segment Elevation Myocardial Infarction

Voight, 2012, Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study, Lancet, 380, 572, 10.1016/S0140-6736(12)60312-2 Shaw, 2008, Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque, Circ Res, 103, 1084, 10.1161/CIRCRESAHA.108.182063 Tall, 2018, Trials and tribulations of CETP inhibitors, Circ Res, 122, 106, 10.1161/CIRCRESAHA.117.311978 Ronsein, 2017, Time to ditch HDL-C as a measure of HDL function?, Curr Opin Lipidol, 28, 414, 10.1097/MOL.0000000000000446 Khera, 2011, Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis, N Engl J Med, 364, 127, 10.1056/NEJMoa1001689 Rohatgi, 2014, HDL cholesterol efflux capacity and incident cardiovascular events, N Engl J Med, 371, 2383, 10.1056/NEJMoa1409065 Saleheen, 2015, Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study, Lancet Diabetes Endocrinol, 3, 507, 10.1016/S2213-8587(15)00126-6 Ritsch, 2015, HDL cholesterol efflux capacity and cardiovascular events, N Engl J Med, 372, 1870 Liu, 2016, Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: a prospective cohort study, Atherosclerosis, 249, 116, 10.1016/j.atherosclerosis.2015.10.111 Gibson, 2016, Safety and tolerability of CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I, after acute myocardial infarction: the AEGIS-I trial (ApoA-I Event Reducing in Ischemic Syndromes I), Circulation, 134, 1918, 10.1161/CIRCULATIONAHA.116.025687 Anastasius, 2016, Cholesterol efflux capacity: an introduction for clinicians, Am Heart J, 180, 54, 10.1016/j.ahj.2016.07.005 Jessup, 2006, Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages, Curr Opin Lipidol, 17, 247, 10.1097/01.mol.0000226116.35555.eb Adorni, 2007, The roles of different pathways in the release of cholesterol from macrophages, J Lipid Res, 48, 2453, 10.1194/jlr.M700274-JLR200 Larrede, 2009, Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent, Arterioscler Thromb Vasc Biol, 29, 1930, 10.1161/ATVBAHA.109.194548 Vergeer, 2011, Genetic variant of the scavenger receptor BI in humans, N Engl J Med, 364, 136, 10.1056/NEJMoa0907687 Hoang, 2012, Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein, Eur Heart J, 33, 657, 10.1093/eurheartj/ehr103 Villard, 2012, Elevated CETP activity improves plasma cholesterol efflux capacity from human macrophages in women, Arterioscler Thromb Vasc Biol, 32, 2341, 10.1161/ATVBAHA.112.252841 Gall, 2016, Association of cholesterol efflux capacity with clinical features of metabolic syndrome: relevance to atherosclerosis, J Am Heart Assoc, 5, e004808, 10.1161/JAHA.116.004808 Villard, 2013, Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels, Arterioscler Thromb Vasc Biol, 33, 822, 10.1161/ATVBAHA.112.300979 El Khoury, 2016, Extended-release niacin/laropiprant improves overall efficacy of postprandial reverse cholesterol transport, Arterioscler Thromb Vasc Biol, 36, 285, 10.1161/ATVBAHA.115.306834 Silvain, 2018, Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention, Heart, 104, 767, 10.1136/heartjnl-2017-311975 Annema, 2016, HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels, J Clin Lipidol, 10, 1318, 10.1016/j.jacl.2016.08.003 Le Goff, 2004, Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia, Pharmacol Ther, 101, 17, 10.1016/j.pharmthera.2003.10.001 Barter, 2007, Effects of torcetrapib in patients at high risk for coronary events, N Engl J Med, 357, 2109, 10.1056/NEJMoa0706628 Schwartz, 2012, Effects of dalcetrapib in patients with a recent acute coronary syndrome, N Engl J Med, 367, 2089, 10.1056/NEJMoa1206797 Lincoff, 2017, Evacetrapib and cardiovascular outcomes in high-risk vascular disease, N Engl J Med, 376, 1933, 10.1056/NEJMoa1609581 Schwartz, 2004, Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans, J Lipid Res, 45, 1594, 10.1194/jlr.M300511-JLR200 Rohatgi, 2015, High-density lipoprotein function measurement in human studies: focus on cholesterol efflux capacity, Prog Cardiovasc Dis, 58, 32, 10.1016/j.pcad.2015.05.004 Williams, 1999, Scavenger receptor BI and cholesterol trafficking, Curr Opin Lipidol, 10, 329, 10.1097/00041433-199908000-00007 Tréguier, 2007, LDL particle subspecies are distinct in their capacity to mediate free cholesterol efflux via the SR-BI/Cla-1 receptor, Biochim Biophys Acta, 1771, 129, 10.1016/j.bbalip.2006.12.004